UK Markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.19+0.07 (+0.86%)
At close: 4:00PM EDT

Avadel Pharmaceuticals plc

10 Earlsfort Terrace
Dublin 2
353 1 485 1200

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees32

Key executives

NameTitlePayExercisedYear born
Mr. Gregory J. Divis Jr.CEO & Director897kN/A1967
Mr. Thomas S. McHughSr. VP & CFO581.2kN/A1965
Dr. Jordan S. Dubow M.D.Consultant727.93k395.25k1978
Mr. Gregory J. DavisVP of Corp. and Bus. Devel.N/AN/A1965
Mr. Mark W. ElrodVP of SalesN/AN/AN/A
Ms. Angie WoodsVP of People & CultureN/AN/AN/A
Mr. Christian Kalita Pharm.DChief Pharmacist and Director of Quality Assurance & Regulatory AffairsN/AN/AN/A
Mr. Steven G. SullivanVP of Sales & Marketing and Head of Commercial OperationsN/AN/A1965
Dr. Jason M. VaughnSr. VP of Technical OperationsN/AN/AN/A
Mr. Richard KimChief Commercial OfficerN/AN/A1969
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Corporate governance

Avadel Pharmaceuticals plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.